PALISADE BIO, INC. Quarterly Entity Common Stock, Shares Outstanding from Q2 2011 to Q2 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Palisade Bio, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q2 2011 to Q2 2024.
  • Palisade Bio, Inc. Entity Common Stock, Shares Outstanding for the quarter ending August 5, 2024 was 1.18M shares, a 82.7% decline year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 1.18M -5.67M -82.7% Aug 5, 2024 10-Q 2024-08-12
Q1 2024 12.8M +8.27M +184% Mar 21, 2024 10-K 2024-03-26
Q3 2023 9.22M -67.9M -88% Nov 6, 2023 10-Q 2023-11-09
Q2 2023 6.86M -15M -68.7% Aug 8, 2023 10-Q 2023-08-10
Q1 2023 4.5M -13.7M -75.3% Mar 15, 2023 10-K 2023-03-22
Q3 2022 77.1M +63.5M +468% Nov 10, 2022 10-Q 2022-11-14
Q2 2022 21.9M Aug 11, 2022 10-Q 2022-08-15
Q1 2022 18.2M +938K +5.42% Mar 16, 2022 10-K 2022-03-17
Q3 2021 13.6M -3.72M -21.5% Nov 10, 2021 10-Q 2021-11-12
Q1 2021 17.3M +7.87M +83.5% Feb 28, 2021 10-K 2021-03-22
Q3 2020 17.3M +13.4M +347% Oct 31, 2020 10-Q 2020-11-10
Q2 2020 17.3M +15.2M +723% Jul 31, 2020 10-Q 2020-08-13
Q1 2020 9.43M -10.6M -52.9% Apr 30, 2020 10-Q 2020-05-15
Q3 2019 3.87M -14.3M -78.8% Nov 5, 2019 10-Q 2019-11-14
Q2 2019 2.1M -13.1M -86.1% Aug 8, 2019 10-Q 2019-08-14
Q1 2019 20M +4.85M +32% Apr 30, 2019 10-Q 2019-05-14
Q3 2018 18.2M +3.06M +20.2% Oct 31, 2018 10-Q 2018-11-14
Q2 2018 15.2M +3.04M +25.1% Jul 31, 2018 10-Q 2018-08-13
Q1 2018 15.2M +3.26M +27.4% Apr 30, 2018 10-Q 2018-05-15
Q3 2017 15.1M -99.7M -86.8% Oct 31, 2017 10-Q 2017-11-08
Q2 2017 12.1M -103M -89.4% Jul 31, 2017 10-Q 2017-08-08
Q1 2017 11.9M -80.1M -87.1% Apr 30, 2017 10-Q 2017-05-10
Q3 2016 115M +23.1M +25.1% Oct 31, 2016 10-Q 2016-11-08
Q2 2016 115M +23M +25% Jul 31, 2016 10-Q 2016-08-11
Q1 2016 92M +1.71M +1.89% Apr 30, 2016 10-Q 2016-05-09
Q3 2015 91.8M +4.43M +5.07% Oct 31, 2015 10-Q 2015-11-09
Q2 2015 91.8M +4.95M +5.7% Jul 31, 2015 10-Q 2015-08-10
Q1 2015 90.3M +3.57M +4.12% Apr 30, 2015 10-Q 2015-05-08
Q3 2014 87.4M +10.7M +14% Oct 31, 2014 10-Q 2014-11-07
Q2 2014 86.8M +15.2M +21.2% Jul 31, 2014 10-Q 2014-08-08
Q1 2014 86.8M +18M +26.1% Apr 30, 2014 10-Q 2014-05-12
Q3 2013 76.7M +8.67M +12.8% Oct 31, 2013 10-Q 2013-11-12
Q2 2013 71.6M +17.6M +32.5% Jul 31, 2013 10-Q 2013-08-08
Q1 2013 68.8M +14.9M +27.7% Apr 30, 2013 10-Q 2013-05-10
Q3 2012 68M +19.3M +39.7% Oct 31, 2012 10-Q 2012-11-09
Q2 2012 54.1M +5.61M +11.6% Jul 31, 2012 10-Q 2012-08-09
Q1 2012 53.9M Mar 1, 2012 10-K 2012-03-30
Q3 2011 48.7M Nov 1, 2011 10-Q 2011-11-09
Q2 2011 48.5M Aug 1, 2011 10-Q/A 2011-09-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.